Abstract
Familial Exudative Vitreoretinopathy (FEVR) is a hereditary eye disorder, first reported in 1969 by Criswick and Schepens. It affects both the retina and the vitreous body, and is characterized by an abnormal vascularization of the peripheral retina. In the majority of cases, it is inherited in an autosomal dominant manner, but recently, a series of cases with an X-linked recessive and a few families with an autosomal recessive inheritance have also been reported. While linkage analysis has not been reported for the autosomal recessive form, the gene for the autosomal dominant form has been localized to the long arm of chromosome 11 (11q13 -q23). DNA linkage analysis of X-linked families has mapped the FEVR gene to Xp11.3 - p11.4. This is also a locus for Norrie disease (ND) which is a bilateral X-linked recessive disorder, characterized by ocular dysgenesis, progressive mental retardation and deafness. The cloning of the ND gene has made it possible to investigate the etiology of ND, as well as seve ral other clinically similar conditions. The ND gene product is ubiquitously expressed in tissues, including the brain, retina and cochlea, but not the liver. Mutational analysis of the ND gene identified the entire spectrum of segregating mutations in ND, as well as in some X-linked FEVR families, implying that ND and X-linked FEVR are allelic disorders. However, in some other X-linked FEVR families, no disease-causing mutations in the ND gene have been identified, indicating that X-linked FEVR is a genetically heterogeneous disorder. Although X-linked recessive disorders generally do not affect females, it has been shown that ND and X-linked FEVR can occur in female carriers, likely due to an unfavorable X-inactivation. The above studies have greatly improved our understanding of the retinal degeneration in ND and X-linked FEVR at the molecular level. The availability of an animal model should assist in developing a therapeutic approach, either to delay or to prevent these devastating disorders in the futur e.
Keywords: Molecular Genetics, Norrie Disease, Familial Exudative Vitreoretinopathy, X-linked FEVR, Mutational Analysis
Current Genomics
Title: Molecular Genetics of Familial Exudative Vitreoretinopathy and Norrie Disease
Volume: 1 Issue: 3
Author(s): Barkur S. Shastry and Miki Hiraoka
Affiliation:
Keywords: Molecular Genetics, Norrie Disease, Familial Exudative Vitreoretinopathy, X-linked FEVR, Mutational Analysis
Abstract: Familial Exudative Vitreoretinopathy (FEVR) is a hereditary eye disorder, first reported in 1969 by Criswick and Schepens. It affects both the retina and the vitreous body, and is characterized by an abnormal vascularization of the peripheral retina. In the majority of cases, it is inherited in an autosomal dominant manner, but recently, a series of cases with an X-linked recessive and a few families with an autosomal recessive inheritance have also been reported. While linkage analysis has not been reported for the autosomal recessive form, the gene for the autosomal dominant form has been localized to the long arm of chromosome 11 (11q13 -q23). DNA linkage analysis of X-linked families has mapped the FEVR gene to Xp11.3 - p11.4. This is also a locus for Norrie disease (ND) which is a bilateral X-linked recessive disorder, characterized by ocular dysgenesis, progressive mental retardation and deafness. The cloning of the ND gene has made it possible to investigate the etiology of ND, as well as seve ral other clinically similar conditions. The ND gene product is ubiquitously expressed in tissues, including the brain, retina and cochlea, but not the liver. Mutational analysis of the ND gene identified the entire spectrum of segregating mutations in ND, as well as in some X-linked FEVR families, implying that ND and X-linked FEVR are allelic disorders. However, in some other X-linked FEVR families, no disease-causing mutations in the ND gene have been identified, indicating that X-linked FEVR is a genetically heterogeneous disorder. Although X-linked recessive disorders generally do not affect females, it has been shown that ND and X-linked FEVR can occur in female carriers, likely due to an unfavorable X-inactivation. The above studies have greatly improved our understanding of the retinal degeneration in ND and X-linked FEVR at the molecular level. The availability of an animal model should assist in developing a therapeutic approach, either to delay or to prevent these devastating disorders in the futur e.
Export Options
About this article
Cite this article as:
Shastry S. Barkur and Hiraoka Miki, Molecular Genetics of Familial Exudative Vitreoretinopathy and Norrie Disease, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351445
DOI https://dx.doi.org/10.2174/1389202003351445 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design Recent Advances in Two-Photon Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer
Current Pharmaceutical Biotechnology Ultrasound Therapeutics– A Review
Current Medical Imaging Advances in Ocular Iontophoresis Research
Recent Patents on Nanomedicine Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Current Cancer Therapy Reviews Recent Advancements for the Management of Pancreatic Cancer: Current Insights
Current Cancer Therapy Reviews Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
Current Cancer Drug Targets Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
Current Drug Targets Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Current Medicinal Chemistry HER-2 / neu and Topoisomerase IIα - Simultaneous Drug Targets in Cancer
Combinatorial Chemistry & High Throughput Screening Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Pharmacology and Therapeutic Applications of Enediyne Antitumor Antibiotics
Current Molecular Pharmacology Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers
Current Medicinal Chemistry